CEL-SCI (NYSE: CVM) awards CEO 300,000 options over 3 years

Rhea-AI Filing Summary

CEL SCI CORP director and Chief Executive Officer Geert R. Kersten received a grant of 300,000 stock options on 2026-08-14. The options have an exercise price of $1.49 per share, a grant-date fair value of $0.01 per option, and expire on 2036-08-13. They vest in three equal annual installments starting one year after the grant date. Following this grant, Kersten directly holds 452,380 options in total.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KERSTEN GEERT R

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Options F1	300,000	$0.01	$3K

Holdings After Transaction: Options — 452,380 shares (Direct)

Footnotes (1)

1. F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Key Figures

Options granted: 300,000 options Exercise price: $1.49 per share Grant price per option: $0.01 per option +3 more

6 metrics

Options granted 300,000 options Derivative award to CEO on 2026-08-14

Exercise price $1.49 per share Exercise price of granted stock options

Grant price per option $0.01 per option Transaction price per option for the award

Underlying shares 300,000 shares Common stock underlying the option award

Expiration date 2036-08-13 Expiration of the granted stock options

Options held after grant 452,380 options Total directly held options following the transaction

Key Terms

stock options, exercise price, expiration date, vesting

4 terms

stock options financial

"The stock options vest in three (3) equal annual installments"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"conversion_or_exercise_price": "1.4900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2036-08-13""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"vest in three (3) equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What insider transaction did CVM CEO Geert R. Kersten report on this Form 4?

Geert R. Kersten reported a grant of 300,000 stock options in CEL SCI CORP (CVM). These options were awarded as a derivative acquisition, not a market purchase or sale, and increase his total directly held options to 452,380.

What are the key terms of the 300,000 stock options granted to CVM’s CEO?

The grant covers 300,000 options with an exercise price of $1.49 per share and a $0.01 grant-date value. The options expire on 2036-08-13, giving a long exercise window tied to CEL SCI CORP’s common stock.

How do the new options granted affect the CEO’s total holdings in CVM?

After this grant, Geert R. Kersten directly holds 452,380 stock options in CEL SCI CORP. The Form 4 shows these options as derivative securities tied to common stock, reflecting his equity-based compensation position.

How do the CVM CEO’s new stock options vest over time?

The 300,000 stock options vest in three equal annual installments, beginning one year after the grant date. This means one-third of the options becomes exercisable each year over a three-year period, aligning vesting with continued service.

Were the CVM CEO’s reported option grants made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not checked, so these reported option grants are not affirmed as made under a Rule 10b5-1 trading plan. They are reported simply as a compensation-related grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 09:19 AM Accepted by SEC EDGAR 08/17/2026 - 09:19 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$1.49	08/14/2026		A		300,000		(1)	08/13/2036	Common Stock	300,000	$0.01	452,380	D

Explanation of Responses:

1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

	Geert Kersten	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)